Table 1.
Severity of the Disease (PUCAI Score) | Mild | Moderate | Total |
---|---|---|---|
29 (48.3%) | 31 (51.7%) | 60 (100%) | |
Sex, N (%) | |||
Male | 13 (44.8%) | 13 (41.9%) | 26 |
Female | 16 (55.2%) | 18 (58.1%) | 34 |
Mean age at diagnosis (years) | 13.7 | 13.9 | 13.7 |
Mean PUCAI: | |||
At diagnosis | 20.7 | 43.7 | 32.3 |
After 3 months | 2.2 | 5.0 | 3.7 |
Treatment, N (%) | |||
Mesalazine | 29 (100%) | 31 (100%) | 60 (100%) |
Corticosteroids | 18 (62%) | 25 (80.6%) | 43 (71.7%) |
Response rate to initial treatment, N (%) | 26 (89.7%) | 25 (80.6%) | 51 (85%) |
Early relapse, N (%) | 6 (20.7%) | 7 (22.6%) | 13 (21.7%) |
Primary sclerosing cholangitis, N (%) | 6 (20.7%) | 3 (9.7%) | 9 (15%) |